BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
US Department of Justice
Federal Trade Commission
Julphar
Chinese Patent Office
Accenture
Fuji
Covington
Medtronic

Generated: January 17, 2018

DrugPatentWatch Database Preview

MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN Drug Profile

« Back to Dashboard

Which patents cover Mepivacaine Hydrochloride W/ Levonordefrin, and what generic alternatives are available?

Mepivacaine Hydrochloride W/ Levonordefrin is a drug marketed by Belmora Llc and is included in one NDA.

The generic ingredient in MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN
Drug patent expirations by year for MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN

US Patents and Regulatory Information for MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belmora Llc MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084850-002 Oct 21, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
US Department of Justice
AstraZeneca
Argus Health
Cerilliant
Citi
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot